Posts tagged drug products

• Specialized Treatment for HRT Patients With Lobular Breast Cancer

  Brenda Fulmer | December 31, 2007 4:15 PM | 0 CommentsPinellas, FL Category: Defective & Dangerous Products
  

  A study from Turin, Italy published recently in Endocrine Related Cancer noted that former users of hormone replacement therapy drugs who are diagnosed with lobular breast cancers may require specialized treatment based upon the unique characteristics of their tumors. The researchers noted a "growing body of evidence" to "support the association between the use of hormone replacement therapy...

• Closing The Chapter on HRT Litigation in 2007

  Brenda Fulmer | December 31, 2007 3:37 PM | 0 CommentsPinellas, FL Category: Defective & Dangerous Products
  

  Great strides were made in 2007 to educate the courts and juries about the great deception over the past few decades that led many to ingest combination hormone therapy products such as Prempro and Premarin in combination with Provera. Conventional wisdom about these hormones is finally shifting, especially in light of an unprecedented drop in national cancer registries that dovetails with the...

• Yet Another Study Confirming That Discontinuation of HRT Led to Drops in Breast Cancer Rates

  Brenda Fulmer | December 31, 2007 3:06 PM | 0 CommentsPinellas, FL Category: FDA & Prescription Drugs
  

  "Reductions in postmenopausal breast cancer incidence observed in the US were strongest in White women, intermediate in Asian/Pacific Islander and Hispanic women, and absent in African-American women. In all groups, declines were most evident for hormone receptor-positive, lobular, and small cancers. While this and other ecologic analyses cannot definitively speak to the influence of...

• FDA Issues Second Warning About Fentanyl Skin Patch

  Joe Saunders | December 22, 2007 1:09 PM | 0 CommentsPinellas, FL Category: FDA & Prescription Drugs
  

  The FDA has issued another warning about the Fentanyl skin patch used to administer powerful pain medication to patients. The problems with the skin patch have occurred due to misprescribing the drug or improper use of the patch resulting in serious injury and death. The skin patch was approved for use by the FDA in 1990 but has resulted in serious health concerns for users of the patch. ...

• CDC Recommends Delaying HIB Booster Shot

  Shannon Weidemann | December 20, 2007 10:45 PM | 0 CommentsPinellas, FL Category: FDA & Prescription Drugs
  

  It was announced last week that 1.2 Million doses of the HIB vaccine were recalled. The recalled vaccine was manufactured in a Pennsylvania plant that was found to be contaminated. The CDC is concerned of a vaccine shortage and urged doctors to delay the third and final booster shot in the series. The vaccine is given to infants to help prevent pneumonia and meningitis. Normally, the...

• Zyprexa on the Verge of Being Marketed to Children

  Joe Saunders | December 16, 2007 11:08 AM | 0 CommentsPinellas, FL Category: FDA & Prescription Drugs
  

  In today's St. Petersburg Times, there is a front page story about Eli Lilly's apparently successful efforts at marketing the drug Zyprexa to children. The FDA is about to approve the drug's use for children in spite of the dangerous side effects which include diabetes. Children are even more susceptible to these side effects. In the article, I am quoted as saying that Eli LIlly isn't fazed...

• Older Patients Who Take Avandia Have Higher Risk of Heart Attacks

  Joe Saunders | December 13, 2007 11:33 AM | 0 CommentsSarasota, FL Category: FDA & Prescription Drugs
  

  According to an article published in the Journal of the American Medical Association older people who suffer from diabetes and take Avandia as part of their treatment regimen are 60% increased risk of heart failure, a 40% increased risk of heart attack, and a 30% increased risk of death. This is obviously not good news for Glaxo Smith Kline, the manufacturer of Avandia. Avandia is a...

• FDA Strengthens Warnings on Epilepsy Drugs

  Joe Saunders | December 13, 2007 11:27 AM | 0 CommentsPinellas, FL Category: FDA & Prescription Drugs
  

  The Food and Drug Administration has strengthened already tough warnings on certain epilepsy drugs that are also used to treat bipolar disorder and nerve pain. In addition, the FDA singled out those of Asian ancestry to undergo genetic testing prior to beginning any regimen with the drug carbamazepine which is distributed as Carbatrol by Shire PLC, Tegretol by Novartis AG and Equetro by Validus...

• Genentech's Move to Restrict Use of Cheaper Avastin Leads to Probe

  Joe Saunders | December 03, 2007 9:30 AM | 0 CommentsSarasota, FL Category: FDA & Prescription Drugs
  

  Genentech, the maker of Avastin, has sought to restrict access to its cheaper drug Avastin so that health officials will use a more expensive brand has lead to Congressional criticism. The restriction on the eye disease drug has led one US senator to write letters to the Centers for Medicare and Medicaid and the FDA inquiring as to the propriety of Genentech's actions. Senator Kohl of...

• China Working to Clean Up Pharmaceutical Industry

  Joe Saunders | December 03, 2007 9:23 AM | 0 CommentsPinellas, FL Category: FDA & Prescription Drugs
  

  China's scandal ridden pharmaceutical industry is undergoing a massive clean up effort by China's version of the FDA. China has been plagued by health scares due to bad drugs, false advertising, and unlicensed drug manufacturers. One Chinese health official, Zheng Xiaoyu, was sentenced to death last May for taking bribes. In one case of bad drugs, dozens of people in Panama died as a result...